INFUSYSTEMS HLDG.DL-,0001

InfuSystem Holdings appointed Beverly Huss as chair of the board following the 2026 annual meeting, according to SEC filings. The filing notes that there are no agreements, family relationships or reportable transactions related to her appointment. At the same annual meeting, shareholders approved the election of all seven nominated directors and an amendment to the equity participation plan. The company also reported Q1 results: EPS beat expectations at $0.05 versus $0.03, while revenue of $33.7 million was slightly below forecasts. » More on de.investing.com

At the annual meeting, shareholders voted to elect all seven of InfuSystem’s board candidates and gave advisory approval to executive compensation. They also amended the 2021 Equity Incentive Plan, increasing the maximum number of available shares to 7,000,000. Shareholders ratified Grant Thornton as auditor for the fiscal year ending December 31, 2026. InfuSystem also reported Q1 results with EPS of $0.05 (expected $0.03) on revenues of $33.7 million, slightly below expectations. » More on de.investing.com

InfuSystem Holdings’ audit committee appointed Grant Thornton as the new independent auditor for the fiscal year ending December 31, 2026, and removed Deloitte following a competitive process. InfuSystem and its representatives had not engaged Grant Thornton in the fiscal years through 2025 or up to March 13, 2026; Deloitte’s audit opinions for 2024 and 2025 were unmodified and there were no disagreements. The company slightly beat EPS expectations in Q4 2025, missed revenue modestly, and CFO Barry G. Steele made an insider purchase of 2,064 shares. » More on de.investing.com